CRI Funded Scientists

Stephen T. Ferris, PhD, Postdoctoral Fellow

Washington University School of Medicine

Area of Research: All Cancers

Dendritic cells play an important role in the immune system’s ability to mount adaptive responses against cancer. As a result, they are targeted by a variety of immunotherapy strategies, including vaccines that teach the immune system what cancer “looks like.” Then, by displaying these tumor markers on their surface, dendritic cells can stimulate T cells to target and attack cancer cells that have these markers. However, the details of how dendritic cells orchestrate immune response are not fully understood, so Dr. Ferris aims to characterize some of the relevant factors.

In particular, he has identified genes that appear to be essential for effective immune responses mediated by dendritic cells. By characterizing those further—as well as identifying other potential targets involved—he hopes to improve our understanding of what is needed to induce tumor-specific immune responses. In this way, his insights could help enhance existing immunotherapies, including vaccines, as well as pave the way for the development of novel immune-based approaches against cancer.

Projects and Grants

Determining the role of cDC1s beyond cross presentation in anti-tumor immunity

Washington University School of Medicine | All Cancers | 2020 | Kenneth M. Murphy, MD, PhD

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.